BioNTech Surges On Summit's Coattails. But Can They Take On Merck?
In This Article:
BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.
Terms and Privacy Policy